According to a new study, it’s possible to reverse the signs of vertigo in patients with arthritis.
It’s a breakthrough that could be used in conjunction with other treatments for other ailments.
Researchers found that using a vitamin and mineral combination called “r-alpha-tocopherol” for about three weeks improved the patients’ symptoms and quality of life, according to the study, published online today in the journal Nature.
“It’s important to understand the potential for these treatments to help patients who have arthritis, but also for people who don’t have arthritis,” said Dr. Robert J. G. Schuster, a professor of medicine at New York University and co-author of the study.
One of the most effective and well-known anti-inflammatory drugs in the world, r-alpha is a chemical that inhibits the production of an enzyme that breaks down protein.
The anti-inflammatories that were used in the study were given to patients who had arthritis, and those who didn’t had similar symptoms.
“This is the first study to show that r-beta-tocopheryl acetate and alpha-tocotrienol (a vitamin and minerals combination) can reverse the symptoms of arthritis and improve quality of quality of living in patients,” said G. David T. McQuaide, a neurologist at the Cleveland Clinic and the study’s senior author.
The combination of vitamins and minerals was found to work best when patients took two pills a day, a daily dose of 1,500 micrograms, or about the amount in 1,000 mg of Vitamin C. They had to take the vitamin and the mineral every day for four weeks to see the effects.
“The patients we saw had significantly better quality of function, their symptoms resolved,” Dr. T. William Smith, an assistant professor of neurology at NewYork-Presbyterian/Columbia University, told FoxNews.com.
Patients who received vitamin and calcium supplements and who were given an anti-irritant medication had a better quality-of-life than those who got the vitamins alone.
Dr. Smith also noted that the patients who received the combination had a lower chance of developing a new disease.
R-alpha also helps prevent other inflammatory conditions, including rheumatoid arthritis, arthritis, fibromyalgia, psoriasis and diabetes, according a Mayo Clinic press release.
There are currently no FDA-approved drugs that target the production and maintenance of r-α-tocotinic acid.